Financial statements Med - Pharma
Balance sheet data of MED - PHARMA
|
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 2 997 530,70 | 4 084 811,01 | 6 812 448,58 | 5 323 957,53 | 5 505 306,30 |
| A. Fixed assets | 870 898,23 | 511 399,61 | 642 268,78 | 1 576 676,30 | 1 872 365,43 |
| B. Current assets | 2 126 632,47 | 3 573 411,40 | 6 170 179,80 | 3 747 281,23 | 3 632 940,87 |
| C. Share capital contributions (basic funds) | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 2 997 530,70 | 4 084 811,01 | 6 812 448,58 | 5 323 957,53 | 5 505 306,30 |
| A. Equity | -5 897 148,26 | -14 406 703,61 | -27 558 855,83 | -37 951 934,10 | -45 744 821,39 |
| B. Liabilities and provisions for liabilities | 8 894 678,96 | 18 491 514,62 | 34 371 304,41 | 43 275 891,63 | 51 250 127,69 |
| I. Long-term liabilities | - | - | - | - | - |
| II. Short-term liabilities | 8 789 862,86 | 18 101 575,63 | 34 127 566,44 | 43 191 349,88 | 50 763 057,51 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.